“…In this sense, some BCCs have notable antimicrobial activity on some pathogenic species, and some molecular targets have been identified on these microorganisms (proteasomes, penicillin binding proteins, carbonic anhydrases, synthetases, etc.). Consequently, some research groups have applied medicinal chemistry to use this selective cytotoxicity in order to improve the antimicrobial features of some BCCs (Baker, 2011;Dembitsky, 2011;Li, 2013;Onduka, 2013;Sanjoh, 2014;Fu, 2014).…”